304 related articles for article (PubMed ID: 27686970)
1. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.
Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D
Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970
[TBL] [Abstract][Full Text] [Related]
2. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy.
Su J; Zhu S; Liu Z; Jing S; Shen W; Li J
Onkologie; 2012; 35(6):362-7. PubMed ID: 22722457
[TBL] [Abstract][Full Text] [Related]
5. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
Sas-Korczynska B; Sokolowski A; Korzeniowski S
Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
[TBL] [Abstract][Full Text] [Related]
6. Accelerated hypofractionated thoracic radiotherapy in limited disease small cell lung cancer : comparison with the results of conventionally fractionated radiotherapy.
Socha J; Guzowska A; Tyc-Szczepaniak D; Wierzchowski M; Sprawka A; Szczesna A; Kepka L
J BUON; 2015; 20(1):146-57. PubMed ID: 25778310
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.
Koshy M; Malik R; Mahmood U; Rusthoven CG; Sher DJ
Pract Radiat Oncol; 2015; 5(6):374-82. PubMed ID: 26412340
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
9. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
Fried DB; Morris DE; Poole C; Rosenman JG; Halle JS; Detterbeck FC; Hensing TA; Socinski MA
J Clin Oncol; 2004 Dec; 22(23):4837-45. PubMed ID: 15570087
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP; Khuri FR; Curran WJ; Ramalingam SS; Behera M; Higgins KA
Clin Lung Cancer; 2019 Nov; 20(6):484-493.e6. PubMed ID: 31296433
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
[TBL] [Abstract][Full Text] [Related]
12. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated conformal radiotherapy in combination with chemotherapy in limited disease small cell lung cancer patients.
Socha J; Guzowska A; Tyc-Szczepaniak D; Szczęsna A; Kępka L
Pneumonol Alergol Pol; 2014; 82(2):105-15. PubMed ID: 24615194
[TBL] [Abstract][Full Text] [Related]
14. A study of elderly patients with limited-stage small-cell lung cancer after combined chemoradiotherapy.
Su J; Zhu S; Liu Z; Li J; Shen W; Li R
Am J Ther; 2014; 21(5):371-6. PubMed ID: 22975663
[TBL] [Abstract][Full Text] [Related]
15. Utilization of Hyperfractionated Radiation in Small-Cell Lung Cancer and Its Impact on Survival.
Schreiber D; Wong AT; Schwartz D; Rineer J
J Thorac Oncol; 2015 Dec; 10(12):1770-5. PubMed ID: 26334750
[TBL] [Abstract][Full Text] [Related]
16. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.
Salama JK; Hodgson L; Pang H; Urbanic JJ; Blackstock AW; Schild SE; Crawford J; Bogart JA; Vokes EE;
J Thorac Oncol; 2013 Aug; 8(8):1043-9. PubMed ID: 23715301
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations.
Han J; Fu C; Li B
Radiat Oncol; 2021 Mar; 16(1):47. PubMed ID: 33663551
[TBL] [Abstract][Full Text] [Related]
18. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
[TBL] [Abstract][Full Text] [Related]
19. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
20. Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Kubota K; Hida T; Ishikura S; Mizusawa J; Nishio M; Kawahara M; Yokoyama A; Imamura F; Takeda K; Negoro S; Harada M; Okamoto H; Yamamoto N; Shinkai T; Sakai H; Matsui K; Nakagawa K; Shibata T; Saijo N; Tamura T;
Lancet Oncol; 2014 Jan; 15(1):106-13. PubMed ID: 24309370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
